A Randomized Trial of Electronic Clinical Reminders to Improve Medication Laboratory Monitoring

Division of General Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Journal of the American Medical Informatics Association (Impact Factor: 3.93). 04/2008; 15(4):424-9. DOI: 10.1197/jamia.M2602
Source: DBLP

ABSTRACT Recommendations for routine laboratory monitoring to reduce the risk of adverse medication events are not consistently followed. We evaluated the impact of electronic reminders delivered to primary care physicians on rates of appropriate routine medication laboratory monitoring.
We enrolled 303 primary care physicians caring for 1,922 patients across 20 ambulatory clinics that had at least one overdue routine laboratory test for a given medication between January and June 2004. Clinics were randomized so that physicians received either usual care or electronic reminders at the time of office visits focused on potassium, creatinine, liver function, thyroid function, and therapeutic drug levels.
Primary outcomes were the receipt of recommended laboratory monitoring within 14 days following an outpatient clinic visit. The effect of the intervention was assessed for each reminder after adjusting for clustering within clinics, as well as patient and provider characteristics.
Medication-laboratory monitoring non-compliance ranged from 1.6% (potassium monitoring with potassium-supplement use) to 6.3% (liver function monitoring with HMG CoA Reductase Inhibitor use). Rates of appropriate laboratory monitoring following an outpatient visit ranged from 14% (therapeutic drug levels) to 64% (potassium monitoring with potassium-sparing diuretic use). Reminders for appropriate laboratory monitoring had no impact on rates of receiving appropriate testing for creatinine, potassium, liver function, renal function, or therapeutic drug level monitoring.
We identified high rates of appropriate laboratory monitoring, and electronic reminders did not significantly improve these monitoring rates. Future studies should focus on settings with lower baseline adherence rates and alternate drug-laboratory combinations.

Download full-text


Available from: David W Bates, Aug 21, 2015
  • Source
    • "Various international studies have suggested that up to 67% of laboratory test requests in healthcare are inappropriate and can be called into question [2] [3]. Various strategies for changing the test-ordering behavior of medical practitioners, including education programs [4], redesigning the request form [5], feedback on the number or rational basis of tests prescribed [6], informing requesters about the costs of the tests requested [7], and the use Computerized Decision Support Systems (CDSS) [8], have been proposed in the literature. The implementation of guidelines, which are becoming more and more common in medical practice, and compliance with guidelines in daily practice, remain problematic areas [9]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Laboratory tests are not always prescribed appropriately. Guidelines for some important laboratory tests have been developed by expert panels in the Parisian region to maximize the appropriateness of laboratory medicine. However; these recommendations are not frequently consulted by physicians and nurses. We developed a system facilitating consultation of these guidelines, to increase their usability. Elements of information contained in these documents were identified and included in recommendations of different categories. UML modeling was used to represent these categories and their relationships to each other in the guidelines. We used the generated model to implement a computerized interface. The prototype interface, based on web-based technology was found to be rapid and easy to use. By clicking on provided keywords, information about the subject sought is highlighted whilst retaining the entire text of the guideline on-screen.
    Studies in health technology and informatics 01/2011; 169:487-91.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Interruptive alerts within electronic applications can cause "alert fatigue" if they fire too frequently or are clinically reasonable only some of the time. We assessed the impact of non-interruptive, real-time medication laboratory alerts on provider lab test ordering. We enrolled 22 outpatient practices into a prospective, randomized, controlled trial. Clinics either used the existing system or received on-screen recommendations for baseline laboratory tests when prescribing new medications. Since the warnings were non-interruptive, providers did not have to act upon or acknowledge the notification to complete a medication request. Data were collected each time providers performed suggested laboratory testing within 14 days of a new prescription order. Findings were adjusted for patient and provider characteristics as well as patient clustering within clinics. Among 12 clinics with 191 providers in the control group and 10 clinics with 175 providers in the intervention group, there were 3673 total events where baseline lab tests would have been advised: 1988 events in the control group and 1685 in the intervention group. In the control group, baseline labs were requested for 771 (39%) of the medications. In the intervention group, baseline labs were ordered by clinicians in 689 (41%) of the cases. Overall, no significant association existed between the intervention and the rate of ordering appropriate baseline laboratory tests. We found that non-interruptive medication laboratory monitoring alerts were not effective in improving receipt of recommended baseline laboratory test monitoring for medications. Further work is necessary to optimize compliance with non-critical recommendations.
    Journal of the American Medical Informatics Association 11/2008; 16(1):66-71. DOI:10.1197/jamia.M2687 · 3.93 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To establish consensus oral dosing guidelines for primarily renally cleared medications prescribed for older adults. Literature search followed by a two-round modified Delphi survey. A nationally representative survey of experts in geriatric clinical pharmacy. Eleven geriatric clinical pharmacists. After a comprehensive literature search and review by an investigative group of six physicians (2 general internal medicine, 2 nephrology, 2 geriatrics), 43 dosing recommendations for 30 medications at various levels of renal function were created. The expert panel rated its agreement with each of these 43 dosing recommendations using a 5-point Likert scale (1=strongly disagree to 5=strongly agree). Recommendation-specific means and 95% confidence intervals were estimated. Consensus was defined as a lower 95% confidence limit of greater than 4.0 for the recommendation-specific mean score. The response rate was 81.8% (9/11) for the first round. All respondents who completed the first round also completed the second round. The expert panel reached consensus on 26 recommendations involving 18 (60%) medications. For 10 medications (chlorpropamide, colchicine, cotrimoxazole, glyburide, meperidine, nitrofurantoin, probenecid, propoxyphene, spironolactone, and triamterene), the consensus recommendation was not to use the medication in older adults below a specified level of renal function (e.g., creatinine clearance <30 mL/min). For the remaining eight medications (acyclovir, amantadine, ciprofloxacin, gabapentin, memantine, ranitidine, rimantadine, and valacyclovir), specific recommendations for dose reduction or interval extension were made. An expert panel of geriatric clinical pharmacists was able to reach consensus agreement on a number of oral medications that are primarily renally cleared.
    Journal of the American Geriatrics Society 12/2008; 57(2):335-40. DOI:10.1111/j.1532-5415.2008.02098.x · 4.22 Impact Factor
Show more